Nicotine Abuse /Smoking-Related Disease Susceptibility

尼古丁滥用/吸烟相关疾病的易感性

基本信息

  • 批准号:
    6549070
  • 负责人:
  • 金额:
    $ 32.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2007-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): OBJECTIVE: The goals are to determine how nicotine contributes to the dysregulated inflammation and abnormal repair that leads to chronic obstructive lung disease (COPD), the link of nicotine addiction to COPD and the genetic basis for the development of COPD. HYPOTHESIS: We hypothesize that many of the effects of smoking on the lung including the dysregulated inflammatory response and impaired repair that lead to COPD are mediated, in part, by functional alterations induced following the interaction of nicotine with nicotinic acetylcholine receptors (nAChRs) expressed on leukocytes or resident lung cells. We also hypothesize that polymorphisms in nAChRs couple with other common gene-based polymorphisms to increase susceptibility to COPD. SPECIFIC AIMS: The first aim will characterize nAChR expression on leukocytes and selected resident lung cells, and will determine the relationship between receptor expression and cell function. It will test the hypothesis that nicotine's ability to induce inflammation and inhibit repair are dependent on the pattern of nAChR expression on leukocytes and resident lung cells. The second aim will correlate patterns of nAChR expression in inbred mouse strains to susceptibility to COPD. It will test the hypothesis that susceptibility to emphysema in mice is determined by the pattern of nAChR expression. The third aim will determine the relationship between nicotine receptor expression and lung function decline in cigarette smokers. It will test the hypothesis that the pattern of leukocyte nAChR expression predicts lung function decline in COPD subjects. The fourth aim will identify genetic factors that play a role in the development of COPD, focusing, in particular, on the relationships between the genetics of nicotine addiction and those of COPD. It will test the hypothesis that polymorphisms in nAChR couple with other common gene-based polymorphisms to increase susceptibility to COPD.
描述(由申请人提供):目的:旨在确定尼古丁 尼古丁依赖导致炎症失调和异常修复,导致慢性阻塞性肺病(COPD),尼古丁成瘾与COPD的联系以及COPD发展的遗传基础。 假设:我们假设吸烟对肺的许多影响,包括 导致COPD的失调的炎症反应和受损的修复部分是由尼古丁与烟碱乙酰胆碱相互作用后诱导的功能改变介导的 受体(nAChR)表达的白细胞或常驻肺细胞。我们还假设, nAChRs的多态性与其他常见的基于基因的多态性结合, 对COPD的易感性。 具体目标:第一个目标将表征白细胞上的nAChR表达,并选择 受体表达与细胞凋亡之间的关系, 功能它将检验尼古丁诱导炎症和抑制修复的能力取决于白细胞和驻留肺细胞上nAChR表达模式的假设。第二个目标是将近交系小鼠品系中nAChR表达模式与COPD易感性相关联。它将检验小鼠肺气肿易感性由nAChR表达模式决定的假设。第三个目标将确定尼古丁受体表达与吸烟者肺功能下降之间的关系。它将检验白细胞nAChR表达模式预测COPD受试者肺功能下降的假设。第四个目标将确定在COPD发展中发挥作用的遗传因素,特别关注尼古丁成瘾遗传学与COPD遗传学之间的关系。它将检验nAChR多态性与其他常见基因多态性结合增加COPD易感性的假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John R Hoidal其他文献

Chronic Endurance Stress Induces Cardiac Remodeling in Aged Nrf2-Null Mice
  • DOI:
    10.1016/j.freeradbiomed.2012.10.433
  • 发表时间:
    2012-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Dinesh Devadoss;Sellamuthu S. Gounder;Sankaranarayanan Kannan;Naqser Abu-Rmaileh;Kevin S Whitehead;E. Dale Abel;John R Hoidal;Rajasekaran Namakkal-Soorappan
  • 通讯作者:
    Rajasekaran Namakkal-Soorappan
PSS252 - Ablation of Nrf2 Sensitizes Skeletal Muscle to Cardiotoxin Induced Oxidative Stress and Impairs Regeneration
  • DOI:
    10.1016/j.freeradbiomed.2013.10.675
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Naser Abu-Rmaileh;Sankarnarayanan Kannan;Jennifer Hong;Nancy Atieno;Christopher J Davidson;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan
  • 通讯作者:
    Rajasekaran Namakkal Soorappan
Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective
  • DOI:
    10.1007/s11912-020-00992-x
  • 发表时间:
    2021-01-01
  • 期刊:
  • 影响因子:
    5.000
  • 作者:
    Tapan K Mukherjee;Parth Malik;John R Hoidal
  • 通讯作者:
    John R Hoidal
PSS264 - Nrf2 Deficiency Promotes Apoptosis and Impairs Pax7/MyoD Lineage in Aging Skeletal Muscle
  • DOI:
    10.1016/j.freeradbiomed.2013.10.687
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sankarnarayanan Kannan;Christopher J Davidson;Naser Abu-Rmaileh;Russell Richardson;Aldrin V Gomes;John R Hoidal;Rajasekaran Namakkal Soorappan
  • 通讯作者:
    Rajasekaran Namakkal Soorappan

John R Hoidal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John R Hoidal', 18)}}的其他基金

The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8971959
  • 财政年份:
    2013
  • 资助金额:
    $ 32.59万
  • 项目类别:
The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8669718
  • 财政年份:
    2013
  • 资助金额:
    $ 32.59万
  • 项目类别:
The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8544152
  • 财政年份:
    2013
  • 资助金额:
    $ 32.59万
  • 项目类别:
The RAGE of COPD
慢性阻塞性肺病的愤怒
  • 批准号:
    8803306
  • 财政年份:
    2013
  • 资助金额:
    $ 32.59万
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6796754
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6471692
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    6631428
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:
The NAD(P)H Oxidase in Airways Remodeling and Reactivity
NAD(P)H 氧化酶在气道重塑和反应中的作用
  • 批准号:
    7098903
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:
GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
尼古丁成瘾的遗传学和后果
  • 批准号:
    7111760
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:
GENETICS AND CONSEQUENCES OF NICOTINE ADDICTION
尼古丁成瘾的遗传学和后果
  • 批准号:
    6948503
  • 财政年份:
    2002
  • 资助金额:
    $ 32.59万
  • 项目类别:

相似海外基金

ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
  • 批准号:
    493118
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
  • 批准号:
    487508
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
    Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
  • 批准号:
    10633608
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
  • 批准号:
    489950
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
    Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
  • 批准号:
    23K15702
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
  • 批准号:
    10700228
  • 财政年份:
    2023
  • 资助金额:
    $ 32.59万
  • 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
  • 批准号:
    10543560
  • 财政年份:
    2022
  • 资助金额:
    $ 32.59万
  • 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
  • 批准号:
    10449417
  • 财政年份:
    2022
  • 资助金额:
    $ 32.59万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
  • 批准号:
    10772527
  • 财政年份:
    2022
  • 资助金额:
    $ 32.59万
  • 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
  • 批准号:
    10610446
  • 财政年份:
    2022
  • 资助金额:
    $ 32.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了